Evidence map›Paper›PMID 39663462›Full record

ReviewNature reviews. Gastroenterology & hepatology2025

Antibiotic-perturbed microbiota and the role of probiotics.

Hania Szajewska, Karen P Scott, Tim de Meij, Sofia K Forslund-Startceva, Rob Knight, Omry Koren, Paul Little, Bradley C Johnston, Jan Łukasik, Jotham Suez and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Gut microbiota in health and disease.Molecular biomedicine · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hania Szajewska *Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-4596-2874
Karen P Scott *Rowett Institute, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0002-4608-0013
Tim de MeijDepartment of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, Academic Medical Centre, Amsterdam, The Netherlands.
Sofia K Forslund-StartcevaExperimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-4285-6993
Rob KnightDepartment of Pediatrics, University of California San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-0975-9019
Omry KorenAzrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.ORCID http://orcid.org/0000-0002-7738-1337
Paul LittlePrimary Care Research Centre, University of Southampton, Southampton, UK.
Bradley C JohnstonDepartment of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, TX, USA.
Jan ŁukasikDepartment of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-9385-857X
Jotham SuezW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-3836-972X
Daniel J TancrediDepartment of Pediatrics, School of Medicine, University of California Davis, Sacramento, CA, USA.
Mary Ellen SandersInternational Scientific Association for Probiotics and Prebiotics, Consulting Scientific Advisor, Centennial, CO, USA. maryellen@isappscience.org.ORCID http://orcid.org/0000-0001-6321-3423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disruptive effect of antibiotics on the composition and function of the human microbiota is well established. However, the hypothesis that probiotics can help restore the antibiotic-disrupted microbiota has been advanced, with little consideration of the strength of evidence supporting it. Some clinical data suggest that probiotics can reduce antibiotic-related side effects, including Clostridioides difficile-associated diarrhoea, but there are no data that causally link these clinical effects to microbiota protection or recovery. Substantial challenges hinder attempts to address this hypothesis, including the absence of consensus on the composition of a 'normal' microbiota, non-standardized and evolving microbiome measurement methods, and substantial inter-individual microbiota variation. In this Review, we explore these complexities. First, we review the known benefits and risks of antibiotics, the effect of antibiotics on the human microbiota, the resilience and adaptability of the microbiota, and how microbiota restoration might be defined and measured. Subsequently, we explore the evidence for the efficacy of probiotics in preventing disruption or aiding microbiota recovery post-antibiotic treatment. Finally, we offer insights into the current state of research and suggest directions for future research.

Indexed as

Anti-Bacterial AgentsGastrointestinal MicrobiomeProbioticsDiarrheaHumansAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.